Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
Businesswire·2025-12-30 07:37并购交易调查 - 前路易斯安那州总检察长Charles C Foti Jr及KSF律师事务所正在调查Dynavax Technologies Corporation被Sanofi收购的提议 [1] - 根据拟议交易条款Cidara Therapeutics股东持有的每股Cidara股票将获得221.50美元现金 [1] - 调查旨在确定该对价以及达成该对价的流程是否公平 [1]